(S)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide>98.0%(HPLC)1g

Heptafluorobutyric Acid [Sequenation Reagent]>99.0%(T)25g

5-Fluoro-2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 100mg

2-Amino-3-chloro-5-trifluoromethylpyridine>98.0%(GC)25g

1,5-Difluoro-3-methyl-2,4-dinitrobenzene, 95.0%, 100mg

4,5-Dichloro-2-phenyl-3(2H)-pyridazinone>98.0%(GC)1g

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-bis((tert-butyldimethylsilyl)oxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95%, 10g

(S)-Perfluorophenyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoate, 98%, 5g

(3-(2-Methoxy-2-oxoethoxy)phenyl)boronic acid, 95.0%, 100mg

3-(4-Chlorophenyl)-1-methyl-1H-pyrazole-5-carboxylic acid, 10g

Botella de boca estrecha GL 45, 5000 ml, 1 Pieza

3-Amino-4-(butylamino)-n,n-dimethylbenzene-1-sulfonamide, 97%, 250mg

Adamantano, mínimo 99 %, para síntesis, 100 g, envase de vidrio